The upregulation of genomic imprinted DLK1-Dio3 miRNAs in murine lupus is associated with global DNA hypomethylation

PLoS ONE

Volumn 11, Issue 4, 2016, Pages

  Dai, Rujuan ^a   Lu, Ran ^a   Ansar Ahmed, S ^a  

^a VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MICRORNA; MICRORNA 154; MICRORNA 300; MICRORNA 379; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; DLK1 PROTEIN, MOUSE; IODIDE PEROXIDASE; IODOTHYRONINE DEIODINASE TYPE III; SIGNAL PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIO3 GENE; DLK1 GENE; DNA METHYLATION; DOWN REGULATION; FEMALE; GENE; GENE EXPRESSION; GENOME IMPRINTING; MOUSE; NONHUMAN; PATHOGENESIS; SPLEEN CELL; SYSTEMIC LUPUS ERYTHEMATOSUS; T CELL DEPLETION; UPREGULATION; ANIMAL; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; METABOLISM; MURPHY ROTHS LARGE LYMPHOPROLIFERATIVE MOUSE; SPLEEN;

ANIMALS; CYTOKINES; DNA METHYLATION; GENETIC PREDISPOSITION TO DISEASE; GENOMIC IMPRINTING; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; IODIDE PEROXIDASE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, INBRED MRL LPR; MICRORNAS; SPLEEN; UP-REGULATION;

EID: 84963538249     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0153509     Document Type: Article

References (55)

1. Crispin JC, Liossis SN, Kis-Toth K, Lieberman LA, Kyttaris VC, Juang YT, et al. Pathogenesis of human systemic lupus erythematosus: Recent advances. Trends Mol Med. 16(2):47-57. Epub 2010/02/09. doi: S1471-4914(10)00006-7 [pii] doi: 10.1016/j.molmed.2009.12.005 PMID: 20138006; PubMed Central PMCID: PMC2823952.
2. Kono DH, Theofilopoulos AN. Genetics of SLE in mice. Springer Semin Immunopathol. 2006; 28 (2):83-96. Epub 2006/09/15. doi: 10.1007/s00281-006-0030-7 PMID: 16972052.
3. Hewagama A, Richardson B. The genetics and epigenetics of autoimmune diseases. Journal of autoimmunity. 2009; 33(1):3-11. Epub 2009/04/08. doi: 10.1016/j.jaut.2009.03.007 PMID: 19349147; PubMed Central PMCID: PMC2819418.
4. Wolffe AP, Matzke MA. Epigenetics: Regulation through repression. Science (New York, NY. 1999; 286 (5439):481-6. PMID: 10521337.
5. Hedrich CM, Tsokos GC. Epigenetic mechanisms in systemic lupus erythematosus and other autoimmune diseases. Trends Mol Med. 2011; 17(12):714-24. Epub 2011/09/03. doi: 10.1016/j.molmed. 2011.07.005 PMID: 21885342; PubMed Central PMCID: PMC3225699.
6. Richardson BC, Patel DR. Epigenetics in 2013. DNA methylation and miRNA: Key roles in systemic autoimmunity. Nat Rev Rheumatol. 2014; 10(2):72-4. doi: 10.1038/nrrheum.2013.211 PMID: 24418763; PubMed Central PMCID: PMC4332710.
7. Robertson KD. DNA methylation and human disease. Nature reviews Genetics. 2005; 6(8):597-610. Epub 2005/09/02. doi: 10.1038/nrg1655 PMID: 16136652.
8. Balada E, Ordi-Ros J, Vilardell-Tarres M. DNA methylation and systemic lupus erythematosus. Annals of the New York Academy of Sciences. 2007; 1108:127-36. Epub 2007/09/26. PMID: 17893979.
9. Sawalha AH, Jeffries M. Defective DNA methylation and CD70 overexpression in CD4+ T cells in MRL/lpr lupus-prone mice. European journal of immunology. 2007; 37(5):1407-13. Epub 2007/04/13. doi: 10.1002/eji.200636872 PMID: 17429846.
10. Patel DR, Richardson BC. Epigenetic mechanisms in lupus. Current opinion in rheumatology. 2010; 22 (5):478-82. Epub 2010/05/07. doi: 10.1097/BOR.0b013e32833ae915 PMID: 20445453.
11. Quddus J, Johnson KJ, Gavalchin J, Amento EP, Chrisp CE, Yung RL, et al. Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice. The Journal of clinical investigation. 1993; 92 (1):38-53. Epub 1993/07/01. doi: 10.1172/JCI116576 PMID: 7686923; PubMed Central PMCID: PMC293525.
12. Absher DM, Li X, Waite LL, Gibson A, Roberts K, Edberg J, et al. Genome-wide DNA methylation analysis of systemic lupus erythematosus reveals persistent hypomethylation of interferon genes and compositional changes to CD4+ T-cell populations. PLoS genetics. 2013; 9(8):e1003678. doi: 10.1371/journal.pgen.1003678 PMID: 23950730; PubMed Central PMCID: PMC3738443.
13. Coit P, Jeffries M, Altorok N, Dozmorov MG, Koelsch KA, Wren JD, et al. Genome-wide DNA methylation study suggests epigenetic accessibility and transcriptional poising of interferon-regulated genes in naive CD4+ T cells from lupus patients. Journal of autoimmunity. 2013; 43:78-84. doi: 10.1016/j.jaut. 2013.04.003 PMID: 23623029; PubMed Central PMCID: PMC3790645.
14. Javierre BM, Fernandez AF, Richter J, Al-Shahrour F, Martin-Subero JI, Rodriguez-Ubreva J, et al. Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome research. 2010; 20(2):170-9. Epub 2009/12/24. doi: 10.1101/gr.100289.109 PMID: 20028698; PubMed Central PMCID: PMC2813473.
15. Cobb BS, Nesterova TB, Thompson E, Hertweck A, O'Connor E, Godwin J, et al. T cell lineage choice and differentiation in the absence of the RNase III enzyme Dicer. The Journal of experimental medicine. 2005; 201(9):1367-73. Epub 2005/05/04. doi: Jem.20050572 [pii] doi: 10.1084/jem.20050572 PMID: 15867090; PubMed Central PMCID: PMC2213187.
16. Koralov SB, Muljo SA, Galler GR, Krek A, Chakraborty T, Kanellopoulou C, et al. Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell. 2008; 132(5):860-74. Epub 2008/03/11. doi: S0092-8674(08)00268-7 [pii] doi: 10.1016/j.cell.2008.02.020 PMID: 18329371.
17. Chong MM, Rasmussen JP, Rudensky AY, Littman DR. The RNAseIII enzyme Drosha is critical in T cells for preventing lethal inflammatory disease. The Journal of experimental medicine. 2008; 205 (9):2005-17. Epub 2008/08/30. doi: Jem.20081219 [pii] doi: 10.1084/jem.20081219 PMID: 18725527; PubMed Central PMCID: PMC2526196.
18. Muljo SA, Ansel KM, Kanellopoulou C, Livingston DM, Rao A, Rajewsky K. Aberrant T cell differentiation in the absence of Dicer. The Journal of experimental medicine. 2005; 202(2):261-9. Epub 2005/07/13 doi: Jem.20050678 [pii] doi: 10.1084/jem.20050678 PMID: 16009718; PubMed Central PMCID: PMC2212998.
19. Dai R, Ahmed SA. MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases. Translational research: The journal of laboratory and clinical medicine. 2011; 157(4):163-79. Epub 2011/03/23. doi: 10.1016/j.trsl.2011.01.007 PMID: 21420027; PubMed Central PMCID: PMC3072681.
20. Chafin CB, Reilly CM. MicroRNAs implicated in the immunopathogenesis of lupus nephritis. Clinical & developmental immunology. 2013; 2013:430239. doi: 10.1155/2013/430239 PMID: 23983769; PubMed Central PMCID: PMC3741610.
21. Shen N, Liang D, Tang Y, De Vries N, Tak PP. MicroRNAs-novel regulators of systemic lupus erythematosus pathogenesis. Nature reviews Rheumatology. 2012; 8(12):701-9. Epub 2012/10/17. doi: 10. 1038/nrrheum.2012.142 PMID: 23070646.
22. Yan S, Yim LY, Lu L, Lau CS, Chan VS. MicroRNA Regulation in Systemic Lupus Erythematosus Pathogenesis. Immune network. 2014; 14(3):138-48. doi: 10.4110/in.2014.14.3.138 PMID: 24999310; PubMed Central PMCID: PMC4079820.
23. Dai R, Ahmed SA. Sexual dimorphism of miRNA expression: A new perspective in understanding the sex bias of autoimmune diseases. Ther Clin Risk Manag. 2014; 10:151-63. Epub 2014/03/14. doi: 10. 2147/TCRM.S33517 PMID: 24623979; PubMed Central PMCID: PMC3949753.
24. Pan W, Zhu S, Yuan M, Cui H, Wang L, Luo X, et al. MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. J Immunol. 2010; 184(12):6773-81. Epub 2010/05/21. doi: 10.4049/jimmunol.0904060 PMID: 20483747.
25. Zhao S, Wang Y, Liang Y, Zhao M, Long H, Ding S, et al. MicroRNA-126 regulates DNA methylation in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1. Arthritis and rheumatism. 2011; 63(5):1376-86. Epub 2011/05/04. doi: 10.1002/art.30196 PMID: 21538319.
26. Ceribelli A, Yao B, Dominguez-Gutierrez PR, Chan EK. Lupus T cells switched on by DNA hypomethylation via microRNA? Arthritis and rheumatism. 2011; 63(5):1177-81. Epub 2011/05/04. doi: 10.1002/art.30192 PMID: 21538310; PubMed Central PMCID: PMC3201744.
27. Hewagama A, Gorelik G, Patel D, Liyanarachchi P, McCune WJ, Somers E, et al. Overexpression of Xlinked genes in T cells from women with lupus. Journal of autoimmunity. 2013; 41:60-71. Epub 2013/02/26. doi: 10.1016/j.jaut.2012.12.006 PMID: 23434382; PubMed Central PMCID: PMC3622754.
28. Dai R, Zhang Y, Khan D, Heid B, Caudell D, Crasta O, et al. Identification of a common lupus diseaseassociated microRNA expression pattern in three different murine models of lupus. PloS one. 2010; 5 (12):e14302. Epub 2010/12/21. doi: 10.1371/journal.pone.0014302 PMID: 21170274; PubMed Central PMCID: PMC3000827.
29. Benetatos L, Hatzimichael E, Londin E, Vartholomatos G, Loher P, Rigoutsos I, et al. The microRNAs within the DLK1-DIO3 genomic region: Involvement in disease pathogenesis. Cellular and molecular life sciences: CMLS. 2013; 70(5):795-814. Epub 2012/07/25. doi: 10.1007/s00018-012-1080-8 PMID: 22825660.
30. da Rocha ST, Edwards CA, Ito M, Ogata T, Ferguson-Smith AC. Genomic imprinting at the mammalian Dlk1-Dio3 domain. Trends in genetics: TIG. 2008; 24(6):306-16. Epub 2008/05/13. doi: 10.1016/j.tig. 2008.03.011 PMID: 18471925.
31. Seitz H, Royo H, Bortolin ML, Lin SP, Ferguson-Smith AC, Cavaille J. A large imprinted microRNA gene cluster at the mouse Dlk1-Gtl2 domain. Genome research. 2004; 14(9):1741-8. Epub 2004/08/18 doi: 10.1101/gr.2743304 PMID: 15310658; PubMed Central PMCID: PMC515320.
32. Zehavi L, Avraham R, Barzilai A, Bar-Ilan D, Navon R, Sidi Y, et al. Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: Biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor. Molecular cancer. 2012; 11:44. Epub 2012/07/04. doi: 10.1186/1476-4598-11-44 PMID: 22747855; PubMed Central PMCID: PMC3444916.
33. Saito Y, Liang G, Egger G, Friedman JM, Chuang JC, Coetzee GA, et al. Specific activation of micro-RNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer cell. 2006; 9(6):435-43. Epub 2006/06/13. doi: 10.1016/j.ccr.2006.04.020 PMID: 16766263.
34. Zhang L, Volinia S, Bonome T, Calin GA, Greshock J, Yang N, et al. Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proceedings of the National Academy of Sciences of the United States of America. 2008; 105(19):7004-9. Epub 2008/05/07 doi: 10.1073/pnas.0801615105 PMID: 18458333; PubMed Central PMCID: PMC2383982.
35. Karpuzoglu E, Fenaux JB, Phillips RA, Lengi AJ, Elvinger F, Ansar Ahmed S. Estrogen up-regulates inducible nitric oxide synthase, nitric oxide, and cyclooxygenase-2 in splenocytes activated with T cell stimulants: Role of interferon-gamma. Endocrinology. 2006; 147(2):662-71. PMID: 16293660.
36. Dai R, Phillips RA, Ansar Ahmed S. Despite inhibition of nuclear localization of NF-kappa B p65, c-Rel, and RelB, 17-beta estradiol up-regulates NF-kappa B signaling in mouse splenocytes: The potential role of Bcl-3. J Immunol. 2007; 179(3):1776-83. PMID: 17641044.
37. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001; 25(4):402-8. doi: 10.1006/meth.2001.1262 PMID: 11846609.
38. Dai R, Phillips RA, Zhang Y, Khan D, Crasta O, Ahmed SA. Suppression of LPS-induced IFN{gamma} and nitric oxide in splenic lymphocytes by select estrogen-regulated miRNA: A novel mechanism of immune modulation. Blood. 2008; 112(12):4591-7. PMID: 18791161. doi: 10.1182/blood-2008-04-152488
39. Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature. 2005; 438(7068):685-9. PMID: 16258535.
40. Stittrich AB, Haftmann C, Sgouroudis E, Kuhl AA, Hegazy AN, Panse I, et al. The microRNA miR-182 is induced by IL-2 and promotes clonal expansion of activated helper T lymphocytes. Nature immunology. 2010; 11(11):1057-62. Epub 2010/10/12. doi: Ni.1945 [pii] doi: 10.1038/ni.1945 PMID: 20935646.
41. Ohl K, Tenbrock K. Inflammatory cytokines in systemic lupus erythematosus. Journal of biomedicine & biotechnology. 2011; 2011:432595. doi: 10.1155/2011/432595 PMID: 22028588; PubMed Central PMCID: PMC3196871.
42. Beebe AM, Cua DJ, De Waal Malefyt R. The role of interleukin-10 in autoimmune disease: Systemic lupus erythematosus (SLE) and multiple sclerosis (MS). Cytokine & growth factor reviews. 2002; 13(4-5):403-12. PMID: 12220553.
43. Richardson B, Sawalha AH, Ray D, Yung R. Murine models of lupus induced by hypomethylated T cells (DNA hypomethylation and lupus...). Methods in molecular biology. 2012; 900:169-80. doi: 10. 1007/978-1-60761-720-4-8 PMID: 22933069.
44. Dai R, McReynolds S, Leroith T, Heid B, Liang Z, Ahmed SA. Sex differences in the expression of lupus-associated miRNAs in splenocytes from lupus-prone NZB/WF1 mice. Biology of sex differences. 2013; 4(1):19. doi: 10.1186/2042-6410-4-19 PMID: 24175965.
45. Vinuesa CG, Rigby RJ, Yu D. Logic and extent of miRNA-mediated control of autoimmune gene expression. International reviews of immunology. 2009; 28(3-4):112-38. Epub 2009/10/09. doi: 10. 1080/08830180902934909 PMID: 19811318.
46. Xin C, Zhang H, Liu Z. miR-154 suppresses colorectal cancer cell growth and motility by targeting TLR2. Mol Cell Biochem. 2014; 387(1-2):271-7. doi: 10.1007/s11010-013-1892-3 PMID: 24242044.
47. Khan S, Brougham CL, Ryan J, Sahrudin A, O'Neill G, Wall D, et al. miR-379 regulates cyclin B1 expression and is decreased in breast cancer. PLoS One. 2013; 8(7):e68753. doi: 10.1371/journal. pone.0068753 PMID: 23874748; PubMed Central PMCID: PMCPMC3707961.
48. Yu J, Xie F, Bao X, Chen W, Xu Q. miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer. Mol Cancer. 2014; 13:121. doi: 10.1186/1476-4598-13-121 PMID: 24885626; PubMed Central PMCID: PMCPMC4040483.
49. Lin SP, Youngson N, Takada S, Seitz H, Reik W, Paulsen M, et al. Asymmetric regulation of imprinting on the maternal and paternal chromosomes at the Dlk1-Gtl2 imprinted cluster on mouse chromosome 12. Nature genetics. 2003; 35(1):97-102. Epub 2003/08/26. doi: 10.1038/ng1233 PMID: 12937418.
50. Takada S, Paulsen M, Tevendale M, Tsai CE, Kelsey G, Cattanach BM, et al. Epigenetic analysis of the Dlk1-Gtl2 imprinted domain on mouse chromosome 12: Implications for imprinting control from comparison with Igf2-H19. Human molecular genetics. 2002; 11(1):77-86. Epub 2002/01/05. PMID: 11773001.
51. Steshina EY, Carr MS, Glick EA, Yevtodiyenko A, Appelbe OK, Schmidt JV. Loss of imprinting at the Dlk1-Gtl2 locus caused by insertional mutagenesis in the Gtl2 5' region. BMC genetics. 2006; 7:44. Epub 2006/10/04. doi: 10.1186/1471-2156-7-44 PMID: 17014736; PubMed Central PMCID: PMC1609179.
52. Manodoro F, Marzec J, Chaplin T, Miraki-Moud F, Moravcsik E, Jovanovic JV, et al. Loss of imprinting at the 14q32 domain is associated with microRNA overexpression in acute promyelocytic leukemia. Blood. 2014; 123(13):2066-74. Epub 2014/02/05. doi: 10.1182/blood-2012-12-469833 PMID: 24493669.
53. Kameswaran V, Bramswig NC, McKenna LB, Penn M, Schug J, Hand NJ, et al. Epigenetic regulation of the DLK1-MEG3 microRNA cluster in human type 2 diabetic islets. Cell metabolism. 2014; 19 (1):135-45. Epub 2014/01/01. doi: 10.1016/j.cmet.2013.11.016 PMID: 24374217; PubMed Central PMCID: PMC3932527.
54. Zeng TB, He HJ, Han ZB, Zhang FW, Huang ZJ, Liu Q, et al. DNA methylation dynamics of a maternally methylated DMR in the mouse Dlk1-Dio3 domain. FEBS Lett. 2014; 588(24):4665-71. doi: 10.1016/j. febslet.2014.10.038 PMID: 25447521.
55. Carr MS, Yevtodiyenko A, Schmidt CL, Schmidt JV. Allele-specific histone modifications regulate expression of the Dlk1-Gtl2 imprinted domain. Genomics. 2007; 89(2):280-90. doi: 10.1016/j.ygeno. 2006.10.005 PMID: 17126526; PubMed Central PMCID: PMCPMC1802099.